Scoopfeeds — Intelligent news, curated.
FDA accepts Genentech filing for Tecentriq in colon cancer
business

FDA accepts Genentech filing for Tecentriq in colon cancer

Investing.com · Jun 11, 2026, 5:09 AM

FDA accepts Genentech filing for Tecentriq in colon cancer

Read full story on Investing.com → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop